Zylet vs TobraDex in Blepharokeratoconjunctivitis

Clinical trial NCT00447577 · COMPLETED

Trial details

NCT number: NCT00447577
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Blepharokeratoconjunctivitis

Start date: 2007-01-01
Primary completion: 2007-06-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.